CLINICAL_TRIALS
trial_result
· 2021-05-11
Clinical Trial Update: JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus
Summary
Post-marketing surveillance trial update for JARDIANCE in Korean adults with type 2 diabetes; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2021-05-11